跳至主要内容
临床试验/NCT07689591
NCT07689591招募中不适用

Noninvasive Artificial Venous Stasis and Coronary Reperfusion in ST-Segment Elevation Myocardial Infarction:The RE-START STEMI Randomized Trial

Firat University1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2026年8月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
500
试验地点
1
主要终点
Presence of Spontaneous Coronary Reperfusion Before Primary PCI

研究概览

简要总结

This prospective, randomized study was designed to evaluate whether the noninvasive artificial venous stasis / RE-START procedure, administered prior to primary percutaneous coronary intervention, increases the frequency of spontaneous coronary reperfusion in the infarct-related artery.

详细描述

The primary hypothesis of the study is that the application of short-term, controlled venous return restriction via a blood pressure cuff on the non-dominant arm may support thrombus lysis by stimulating endothelial-derived fibrinolytic activity and may increase the rate of spontaneous reperfusion, defined as TIMI 2 or TIMI 3 flow, in the infarct-related artery prior to primary percutaneous coronary intervention.

This study seeks to answer the following key question: In patients with acute STEMI, does the RE-START procedure-administered without delaying standard care or the preparation process for primary percutaneous coronary intervention-increase the incidence of spontaneous coronary reperfusion prior to primary percutaneous coronary intervention compared to a sham/control procedure?

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Having presented within the first 12 hours of symptom onset Being hemodynamically stable (Killip Class I-II)
  • STEMI diagnosis confirmed by coronary angiography
  • Primary PCI (percutaneous coronary intervention) scheduled
  • No pathology in the upper extremity that would prevent cuff application
  • Be capable of providing informed consent and provide consent

排除标准

  • Presence of cardiogenic shock (systolic blood pressure < 90 mmHg and Killip Class III-IV)
  • Cardiac arrest occurring before or after the procedure
  • Need for resuscitation following failed thrombolysis
  • History of prior coronary artery bypass surgery
  • Concurrent acute aortic dissection
  • Venous thromboembolism or pulmonary embolism
  • History of an acute infection within the past 7 days
  • Chronic kidney disease requiring erythropoietin therapy or currently undergoing hemodialysis
  • Presence of liver failure or a hematologic disorder
  • Presence of any chronic inflammatory or autoimmune disease
  • History of any known malignancy (cancer)
  • Current treatment with glibenclamide, corticosteroids, antioxidant vitamins, or cyclosporine at the time of enrollment
  • History of chronic (daily) alcohol consumption
  • Contraindications to aspirin and/or clopidogrel
  • Failure to confirm a STEMI diagnosis via coronary angiography
  • Inability to provide informed consent
  • Pregnancy
  • First 6 months postpartum Conditions in which the administration of thrombolytics is contraindicated

结局指标

主要结局

Presence of Spontaneous Coronary Reperfusion Before Primary PCI

时间窗: Periprocedural

Spontaneous coronary reperfusion will be defined as the presence of TIMI flow grade 2 or 3 in the infarct-related artery on the first diagnostic coronary angiography performed before guidewire crossing and before primary percutaneous coronary intervention

次要结局

  • ST-Segment Resolution After Primary PCI(90 minutes after primary PCI)
  • Left Ventricular Ejection Fraction(Within 48 hours after primary PCI)
  • Peak-to-Baseline D-Dimer Ratio Through Day 3(From baseline to Day 3 or hospital discharge, whichever occurs first)
  • NT-proBNP Level at Hospital Discharge(At hospital discharge)
  • Contrast-Associated Acute Kidney Injury(From baseline to 48-72 hours after primary PCI)

研究者

发起方
Firat University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Mehmet BALİN

MD, Professor

Firat University

研究点 (1)

Loading locations...

相似试验